Ukrainian Journal of Perinatology and Pediatrics. 2023. 3(95): 35-42; doi 10.15574/PP.2023.95.35
Zapopadna Yu. M.
Shupyk National University of Health of Ukraine, Kyiv

For citation: Zapopadna YuM. (2023). Functional state of the fetoplacental complex in pregnant women with HCV infection. Ukrainian Journal of Perinatology and Pediatrics. 3(95): 35-42; doi 10.15574/PP.2023.95.35.
Article received: Apr 03, 2023. Accepted for publication: Sep 10, 2023.

Purpose – to study the functional state of the fetoplacental complex (FPC) during pregnancy in women with hepatitis C virus (HCV infection).
Materials and methods. A prospective clinical and statistical analysis of the functional state of the FP during pregnancy in 40 women (main group, MG) with HCV infection was conducted on the basis of the Kyiv City Center of Reproductive and Perinatal Medicine for the period 2020-2021. The control group (CG) consisted of 50 healthy pregnant women. Statistical processing of research results was carried out using standard programs Microsoft Excel 5.0 and Statistica 8.0.
Results. The hormonal status of FPK in MG of pregnant women, starting from the 18t^h week, was characterised by a significant decrease in the secretion of progesterone (PG) (159.3±14.6 nmol/l in MG versus 205.4±4.8 nmol/l in CG; p<0.05) and human chorionic gonadotropin (39.2±4.6 mIU/mL versus 52.8±5.3 mIU/mL, respectively). Estradiol (E2) levels in MG of pregnant women from the 18^th week of pregnancy were significantly lower (26.3±2.7 nmol/l) than in CG of pregnant women (33.7±1.4 nmol/l, p<0.05). A synchronous decrease in the level of PG and E2 was observed in the case of threatened abortion against the background of bloody discharge, which indicated clinical manifestations of placental dysfunction (PD). In MG of pregnant women, the level of placental lactogen (PL) at week 18 was almost the same (80.9±13.2 nmol/l) compared to CG of pregnant women (79.5±7.1 nmol/l; p>0.05). From the 29^th week, the level of E2 in MG of pregnant women is significantly different from CG (25.6±1.3 nmol/l in MG versus 51.2±0.7 nmol/l in CG; p<0.05). The most pronounced difference was the level of estriol (E3) and cortisol (Cr) in blood serum relative to CG in MG of pregnant women, which was manifested by a decrease in the level of E3 (up to 86.4±5.2 nmol/l in MG versus 98.4±2.6 nmol/l in CG; p<0.05) against the background of a simultaneous increase in Cr content (up to 751.1±18.6 nmol/l in MG versus 625.6±18.4 nmol/l in CG; p<0.05). Endocrinological disorders also changed before delivery (39-40 weeks): the E2 level decreased (to 45.4±1.9 nmol/l in MG versus 65.3±0.6 nmol/l in CG; p<0.05), E3 (up to 28.3±2.0 nmol/l versus 57.8±1.8 nmol/l, respectively; p<0.01), PG (up to 499.4±11.6 nmol/l versus 604,2±16.3 nmol/l, respectively; p<0.05) and PL (up to 201.4±12.4 nmol/l versus 63.4±18.8 nmol/l, respectively; p<0.05) and the Cr content increased (up to 812.4±16.7 nmol/l versus 651.6±14.6 nmol/l, respectively; p<0.01).
Conclusions. The functional state of the FPC in pregnant women with HCV infection, on the eve of delivery, is characterized by a high level of premature maturation of the placenta, changes in the volume of amniotic fluid, due to which significant hemodynamic and endocrinological subcompensated disorders appear, but in some cases they are decompensated, which causes disorders from the functional state of the fetus and the high frequency of development of fetal growth retardation syndrome in this group of women.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the institution mentioned in the paper. The informed consent of the patient was obtained for conducting the studies.
No conflict of interests was declared by the authors.
Keywords: HCV infection, course of pregnancy, functional state of the placenta, hormones of the placenta, ultrasound examination of the placenta.

REFERENСЕS

1. Abdel-Wahab N, Talathi S, Lopez-Olivo MA, Suarez-Almazor ME. (2018). Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analy-sis. Lupus. 27 (4): 572-583. https://doi.org/10.1177/0961203317731532; PMid:28945149

2. Barritt AS, Jhaveri R. (2018). Treatment of Hepatitis C during Pregnancy-Weighing the Risks and Benefitsin Contrast to HIV. Current HIV/AIDS reports. 15 (2): 155-161. https://doi.org/10.1007/s11904-018-0386-z; PMid:29470782

3. Chappell CA, Hillier SL, Crowe D, Meyn LA, Bogen DL, Krans EE. (2018). Hepatitis C Virus Screening Among Children Exposed During Pregnancy. Pediatrics. 141 (6): e20173273. https://doi.org/10.1542/peds.2017-3273; PMid:29720535 PMCid:PMC5984711

4. Chilaka VN, Konje JC. (2021). Viral Hepatitis in pregnancy. European journal of obstetrics, gynecology, and reproductive biology. 256: 287-296. https://doi.org/10.1016/j.ejogrb.2020.11.052; PMid:33259998

5. Compagnone A, Catenazzi P, Riccardi R, Zuppa AA. (2019). Mother-to-child transmission of hepatitis C virus. Minerva pediatrica. 71 (2): 174-180. https://doi.org/10.23736/S0026-4946.18.04898-3; PMid:29968442

6. Dibba P, Cholankeril R, Li AA, Patel M et al. (2018). Hepatitis C in Pregnancy. Diseases (Basel, Switzerland). 6 (2): 31. https://doi.org/10.3390/diseases6020031; PMid:29702563 PMCid:PMC6023348

7. El-Shabrawi M, Kamal NM, Mogahed EA, Elhusseini MA, Aljabri MF. (2019). Perinatal transmission of hepatitis C virus: an update. Archives of medical science: AMS. 16 (6): 1360-1369. https://doi.org/10.5114/aoms.2019.83644; PMid:33224335 PMCid:PMC7667440

8. Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, Linas BP. (2018). Perinatal Transmission of Hepatitis C Virus: Defining the Cascade of Care. The Journal of pediatrics. 203: 34-40.e1. https://doi.org/10.1016/j.jpeds.2018.07.006; PMid:30170857 PMCid:PMC6252153

9. Freriksen J, van Seyen M, Judd A, Gibb DM, Collins IJ, Greupink R et al. (2019). Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation – implications for maternal dosing, foetal exposure, and safety for mother and child. Alimentary pharmacology & therapeutics. 50 (7): 738-750. https://doi.org/10.1111/apt.15476; PMid:31448450 PMCid:PMC6773363

10. García-Romero CS, Guzman C, Cervantes A, Cerbón M. (2019). Liver disease in pregnancy: Medical aspects and their implications for mother and child. Annals of hepatology. 18 (4): 553-562. https://doi.org/10.1016/j.aohep.2019.04.009; PMid:31126882

11. Gowda C, Smith S, Crim L, Moyer K, Sánchez PJ, Honegger JR. (2021). Nucleic Acid Testing for Diagnosis of Perinatally Acquired Hepatitis C Virus Infection in Early Infancy. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 73 (9): e3340-e3346. https://doi.org/10.1093/cid/ciaa949; PMid:32640018 PMCid:PMC8563185

12. Huang QT, Hang LL, Zhong M, Gao YF, Luo ML, Yu YH. (2016). Maternal HCV infection is associated with intrauterine fetal growth disturbance: a meta-analysis of observational studies. Medicine. 95: 35. https://doi.org/10.1097/MD.0000000000004777; PMid:27583932 PMCid:PMC5008616

13. Mintser AP. (2018). Statisticheskie metodyi issledovaniya v klinicheskoy meditsine. Prakticheskaya meditsina. 3: 41-45.

14. Public Health Center. (2018). Hepatitis C in Ukraine: epidemiological characteristics and severity assessment.

15. Ragusa R, Corsaro LS, Frazzetto E, Bertino E, Bellia MA, Bertino G. (2020). Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments. AJP reports. 10 (1): e121-e127. https://doi.org/10.1055/s-0040-1709185; PMid:32257593 PMCid:PMC7108952

16. Rahim MN, Pirani T, Williamson C, Heneghan MA. (2021). Management of pregnancy in women with cirrhosis. United European gastroenterology journal. 9 (1): 110-119. https://doi.org/10.1177/2050640620977034; PMid:33259738 PMCid:PMC8259114

17. Razavi H. (2020). Global epidemiology of viral hepatitis. Gastroenterology Clinics. 49 (2): 179-189. https://doi.org/10.1016/j.gtc.2020.01.001; PMid:32389357

18. Roudot-Thoraval F. (2021). Epidemiology of hepatitis C virus infection. Clinics and research in hepatology and gastroenterology. 45 (3): 101596. https://doi.org/10.1016/j.clinre.2020.101596; PMid:33610022

19. World Health Organization. (2017). Global hepatitis report 2017: World Health Organization. URL: https://reliefweb.int/report/world/global-hepatitis-report-2017?gclid=Cj0KCQjwi7GnBhDXARIsAFLvH4kONql-Zm6m7CCmw0TiT9dBzPzXfGKGzaKx8NKoh-AeqdCcU9xLV0gaAiqzEALw_wcB.

20. Zhang Y, Chen J, Liao T, Chen S, Yan J, Lin X. (2020). Maternal HBsAg carriers and pregnancy outcomes: a retrospective cohort analysis of 85,190 pregnancies. BMC Pregnancy and Childbirth. 20: 1-9. https://doi.org/10.1186/s12884-020-03257-4; PMid:33238912 PMCid:PMC7687687